Audio

Community Oncology Podcast - Carfilzomib and multiple myeloma

Publish date: September 30, 2012
By
Dr. David Henry

 

What’s the role of parenteral iron use in the oncology clinic? How does carfilzomib fit into the treatment of multiple myeloma? Listen to the the September podcast of Community Oncology from Editor-in-Chief Dr. David H. Henry.

Recommended Reading

Long-Term Zoledronic Acid Does Not Increase ONJ in Myeloma
MDedge Hematology and Oncology
Blinatumomab Gets Complete Response in Acute Lymphoblastic Leukemia
MDedge Hematology and Oncology
Washington Post Blasts Proliferation of ESAs for Anemia
MDedge Hematology and Oncology
Carfilzomib Given the Go-Ahead for Multiple Myeloma
MDedge Hematology and Oncology
Cancer Patients Differ With Docs on QoL Issues
MDedge Hematology and Oncology
Ovarian Cortex Autografts in Cancer Survivors Yield Live Births
MDedge Hematology and Oncology
Acetyl-l-Carnitine Yields Mixed Results for Chemo-Induced Neuropathy
MDedge Hematology and Oncology
Long-Term Follow-Up Warranted After Gastric MALT Lymphoma Remission
MDedge Hematology and Oncology
Sizing up the costs and availability of drugs
MDedge Hematology and Oncology
Carfilzomib and bortezomib therapy in patients with multiple myeloma
MDedge Hematology and Oncology